MD| The primary impact of the amendment is to increase the capacity of hospitals and pharmacies to provide medical and pharmaceutical care if there is a strain on the supply of providers due to the surge of patients related to COVID-19.
In addition to previous emergency orders, this amendment may require insurers to:
- Waive time restrictions on prescription refills
- Waive restrictions on the time or replacement of durable medical equipment such as eyeglasses and dentures
- Waive cost-sharing and copays – including lab fees and vaccinations
- Make a claims payment for treatment of COVID-19 that may be considered experimental
- Evaluate requests for out-of-network providers
- Waive prior authorization for testing
- Expedite grievance procedure for claims denial
- Random audit suspensions by Pharmacy Benefit Managers
Emergency Status Began April 28, 2020, and Expires October 12, 2020